Log in

NASDAQ:SUPG - Astex Pharmaceuticals Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Astex Pharmaceuticals, Inc., formerly SuperGen, Inc. is a pharmaceutical company. The Company is primarily engaged in the discovery and development of small molecule therapeutics with a focus on oncology and hematology. The Company is developing a pipeline of medicines for partnership with pharmaceutical companies. It is also engaged in the application of fragment-based drug discovery and development of small-molecule therapeutics. Using its fragment-based drug discovery platform, Pyramid, Astex Therapeutics Limited, a wholly owned subsidiary, has built a pipeline of molecularly-targeted drugs for large pharmaceutical partners and internal development that are at various stages of clinical, pre-clinical and early discovery development. In October 2013, Otsuka Holdings Co Ltd announced that its wholly owned subsidiary, Otsuka Pharmaceutical Co., Ltd completed, through its wholly owned indirect subsidiary Autumn Acquisition Corporation, its acquisition of Astex Pharmaceuticals, Inc.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:SUPG
CUSIPN/A
Phone+1-925-5600100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive SUPG News and Ratings via Email

Sign-up to receive the latest news and ratings for SUPG and its competitors with MarketBeat's FREE daily newsletter.


Astex Pharmaceuticals (NASDAQ:SUPG) Frequently Asked Questions

What is Astex Pharmaceuticals' stock symbol?

Astex Pharmaceuticals trades on the NASDAQ under the ticker symbol "SUPG."

Has Astex Pharmaceuticals been receiving favorable news coverage?

Press coverage about SUPG stock has trended very negative on Sunday, according to InfoTrie. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Astex Pharmaceuticals earned a daily sentiment score of -3.0 on InfoTrie's scale. They also assigned news headlines about the healthcare company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Astex Pharmaceuticals.

What other stocks do shareholders of Astex Pharmaceuticals own?

How do I buy shares of Astex Pharmaceuticals?

Shares of SUPG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Astex Pharmaceuticals' official website?

The official website for Astex Pharmaceuticals is http://astx.com/.

How can I contact Astex Pharmaceuticals?

Astex Pharmaceuticals' mailing address is Suite 200, 4140 Dublin Blvd., DUBLIN, CA 94568, United States. The healthcare company can be reached via phone at +1-925-5600100.


MarketBeat Community Rating for Astex Pharmaceuticals (NASDAQ SUPG)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  55 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  97
MarketBeat's community ratings are surveys of what our community members think about Astex Pharmaceuticals and other stocks. Vote "Outperform" if you believe SUPG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SUPG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel